George E Johnson, Black hair company founder, dies
Digest more
Biohacker Bryan Johnson reveals shocking diagnosis
Digest more
Dwayne Johnson on daughters, mom in Moana
Digest more
Johnson County, Sheriff Adam King
Digest more
Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.
Johnson & Johnson has the momentum on its side and it is possible for the stock to increase further. Find out why JNJ stock is a hold.
On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one extra-strength Tylenol capsule. She was dead a few hours later.
Politicians serve on committees that set healthcare policy, monitor government contracts, and shape regulatory frameworks.
Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els van Doesburg and ZAS-CEO Willeke Dijkhoffz pictured ...
Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Thursday told investors why he thinks the stock of Johnson & Johnson is performing well this year even as the broader healthcare sector lags. "With so much momentum, but still a reasonable valuation ...
Ratings for Johnson & Johnson (NYSE:JNJ) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 ...
Johnson & Johnson (NYSE: JNJ) recently reported its Q2 results, with revenues aligning and earnings exceeding our estimates. The company reported revenue of $22.4 billion and adjusted earnings of $2.82 per share, compared to our estimates of $22.5 billion ...
Monday - Friday, 6:00 - 7:00 PM ET As Wall Street navigates a jam-packed start to earnings season, CNBC's Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report. "Sometimes in this game, you do just ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform (DE STSF), an integrated catheter ablation solution that enables electrophysiologists to deliver both radiofrequency (RF) and pulsed field (PF) energy through a single catheter.